Company Name: |
Jinan Mingya Medical Technology Co., Ltd.
|
Tel: |
0531-85828981 |
Email: |
864598798@qq.com |
Products Intro: |
Product Name:4-(8-(benzo[c][1,2,5]oxadiazol-5-yl)-1,7-naphthyridin-6-yl)benzoic acid CAS:426268-06-6 Purity:99% HPLC Package:5KG;1KG
|
Company Name: |
Hubei Xinyuanshun Pharmaceutical Chemical Co., Ltd.
|
Tel: |
027-50664929, 13971561712 |
Email: |
hubxys2001@163.com |
Products Intro: |
Product Name:Benzoic acid, 4-[8-(2,1,3-benzoxadiazol-5-yl)-1,7-naphthyridin-6-yl]- CAS:426268-06-6 Purity:99% Package:1kg;5kg;10kg;25kg
|
Company Name: |
Jikang Chemical Industry Co. , Ltd.
|
Tel: |
0573-85609002 18157336032 |
Email: |
zhejia01@163.com |
Products Intro: |
Product Name:4-(8-(benzo[c][1,2,5]oxadiazol-5-yl)-1,7-naphthyridin-6-yl)benzoic acid CAS:426268-06-6 Purity:98% Package:g;kg
|
Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
15002134094 |
Email: |
marketing@targetmol.cn |
Products Intro: |
Product Name:ABE171 CAS:426268-06-6 Purity:详情请点击官网 Package:1 mg
|
Company Name: |
SynZeal Research Pvt Ltd
|
Tel: |
+1 226-802-2078 |
Email: |
standards@synzeal.com |
Products Intro: |
Product Name:RO-4582640 (4-(8-Benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic acid) CAS:426268-06-6
|
|
| 4-(8-(benzo[c][1,2,5]oxadiazol-5-yl)-1,7-naphthyridin-6-yl)benzoic acid Basic information |
Product Name: | 4-(8-(benzo[c][1,2,5]oxadiazol-5-yl)-1,7-naphthyridin-6-yl)benzoic acid | Synonyms: | 4-(8-(benzo[c][1,2,5]oxadiazol-5-yl)-1,7-naphthyridin-6-yl)benzoic acid;RO-458,2640;RO-4582640 (4-(8-Benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic acid);Benzoic acid, 4-[8-(2,1,3-benzoxadiazol-5-yl)-1,7-naphthyridin-6-yl]-;NVP-ABE-171;4-[8-(2,1,3-Benzoxadiazol-5-yl)-1,7-naphthyridin-6-yl]benzoic Acid;ABE171 | CAS: | 426268-06-6 | MF: | C21H12N4O3 | MW: | 368.35 | EINECS: | | Product Categories: | | Mol File: | 426268-06-6.mol | |
| 4-(8-(benzo[c][1,2,5]oxadiazol-5-yl)-1,7-naphthyridin-6-yl)benzoic acid Chemical Properties |
Boiling point | 592.4±60.0 °C(Predicted) | density | 1.436±0.06 g/cm3(Predicted) | pka | 3.87±0.10(Predicted) |
| 4-(8-(benzo[c][1,2,5]oxadiazol-5-yl)-1,7-naphthyridin-6-yl)benzoic acid Usage And Synthesis |
Uses | 4-[8-(2,1,3-Benzoxadiazol-5-yl)-1,7-naphthyridin-6-yl]benzoic Acid is a phosphodiesterase PDE4D inhibitor that functions as an anti-prostrate cancer therapy in both in vitro and in vivo models. Also functions as phosphodiesterase 4 inhibitor with anti-inflammatory activity with the potential for the treatment of airway inflammatory conditions such as asthma and chronic obstructive pulmonary diseases. |
| 4-(8-(benzo[c][1,2,5]oxadiazol-5-yl)-1,7-naphthyridin-6-yl)benzoic acid Preparation Products And Raw materials |
|